Philip Gorelick, MD

Dr. Gorelick, internationally known expert in stroke and stroke prevention, was the John S. Garvin Professor and Head, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago. He served as a Stroke Fellow under Louis R. Caplan, MD, at Michael Reese Hospital as part of the University of Chicago Neurology Program and as the Director of the University of Illinois Stroke Service in the Department of Neurology where he received the Golden Apple and Alpha Omega Alpha awards for excellence in teaching. He was later the Director of the Stroke Service at Michael Reese Hospital where he received the Langendorf Teaching Award from the Department of Medicine and was the
Director of the Stroke and Neurological Critical Care Service at Rush Medical Center where he was awarded an endowed chair in Neurology — the Jannotta Presidential Chair. Dr. Gorelick is board-certified in Neurology and Vascular Neurology.

Since 1987, Dr. Gorelick has received funding from the National Institutes of Health for such studies as the African American Antiplatelet Stroke Prevention Study, Risk Markers for Dementia After Stroke, and Neuroepidemiology of Multi-Infarct Dementia. His research focus has been identification of risk factors for stroke, first and recurrent stroke prevention, stroke prevention in high risk populations, and elucidating risk factors for vascular forms of cognitive impairment (VCI) and understanding mechanisms of VCI.

Dr. Gorelick received the Feinberg Award for Excellence in Clinical Stroke 2004 from the American Heart Association and the National Stroke Association (NSA) Visionary in Stroke Award. He has also held the Daniel Gainey Lectureship 2005 at Mayo Clinic and the Henry Barnett 2005 Lectureship from the Canadian Stroke Network. Dr. Gorelick has been cited by Good Housekeeping as one of the top Stroke Neurologists in the United States and is a member of the Goddess Fund
Stroke Advisory Board, Board of Directors of the NSA, and Advisory Board for the American Stroke Association.

Read a article about the appointment of Dr. Gorelick as medical director of Mercy Health Hauesntein Neurosciences.

Read a Grand Rapids Business Journal article about our Vampire Bat Saliva Study featuring Dr. Gorelick.